http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-2011541-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac23d5fd168fd5be2b72105a2c1be646 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2011-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0467d5ed918a62a34792359816fa26a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec91026f82928a9eeddc4e00ccafacc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a45aae5ee6ffa56dd8b9b737a91823 |
| publicationDate | 2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-2011541-A3 |
| titleOfInvention | Compositions for the treatment of inflammatory diseases |
| abstract | The composition for the treatment of inflammatory diseases, in particular skin, mucous membranes or other tissue, comprises 0.01 to 20% by weight of the present invention. boswellic acids in the form of an extract or an isolate derived from plants of the genus Boswellia, the genus Burseraceae or salts thereof and 0.001 to 30 wt. synthetic cannabidiol. Preferably, the extracts containing boswellic acids or their salts and the synthetic cannabidiol dissolved in a lipophilic solvent selected from the group may be triglycerides, hydrocarbons, alcohols, ketones, esters or ethers. |
| priorityDate | 2011-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.